CHAMPIONS ONCOLOGY INC (CSBR) Stock Analyst Ratings
USA - NASDAQ:CSBR - US15870P3073 - Common Stock
6.78 USD
+0.04 (+0.59%)
ChartMill assigns a Buy % Consensus number of 83% to CSBR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is 80.53% above the current price.
CSBR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CSBR.
In the previous month the buy percentage consensus was at a similar level.
CSBR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-12-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-09-12 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2024-03-13 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-09-22 | Roth MKM | Maintains | Buy -> Buy |
| 2021-03-15 | Roth Capital | Maintains | Buy |
CHAMPIONS ONCOLOGY INC / CSBR FAQ
What is the price target for CSBR stock?
7 analysts have analysed CSBR and the average price target is 12.24 USD. This implies a price increase of 80.53% is expected in the next year compared to the current price of 6.78.
What is the consensus rating for CSBR stock?
The consensus rating for CHAMPIONS ONCOLOGY INC (CSBR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CHAMPIONS ONCOLOGY INC (CSBR)?
The number of analysts covering CHAMPIONS ONCOLOGY INC (CSBR) is 7.